American Journal of Medicine and Medical Sciences

p-ISSN: 2165-901X    e-ISSN: 2165-9036

2021;  11(5): 362-366

doi:10.5923/j.ajmms.20211105.02

Received: Apr. 7, 2021; Accepted: Apr. 23, 2021; Published: Apr. 30, 2021

 

Efficacy and Safety of New Myocardial Stabilizer for Off-Pump Coronary Artery Bypass Grafting

Abdurakhmanov A. A.

Department of Cardiac Surgery, Republican Research Centre of Emergency Medicine, Tashkent, Uzbekistan

Correspondence to: Abdurakhmanov A. A., Department of Cardiac Surgery, Republican Research Centre of Emergency Medicine, Tashkent, Uzbekistan.

Copyright © 2021 The Author(s). Published by Scientific & Academic Publishing.

This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/

Abstract

The aim of the study was to evaluate the newly developed myocardial stabilizer in an experimental model in dogs. Introduction. Off-pump Coronary artery bypass grafting is still a technically challenging procedure. It has been demonstrated that mechanical stabilizers used to locally restrict cardiac excursion exhibit significant residual mobility that can lead to difficulty in performing the surgical procedure. Materials and methods. The study included 4 mongrel dogs weighing 12 to 20 kg. Surgical intervention was performed through theleft thoracotomy using a myocardial stabilizer. During the procedure, blood pressure, heart rate and oxygen saturation, as well as the dynamics of the CT segment on the ECG, were continuously measured. Results. During the experiment, there was no statistically significant change in blood pressure, heart rate, saturation and ECG. All experimental animals survived. No complications were noted. Conclusion. It can be noted that the myocardial stabilizer developed by heart team of Republican Research Center of Emergency Medicine provides excellent stabilization of the target segments of the coronary artery and facilitates vascular anastomosis on the beating heart.

Keywords: Off-pump coronary artery grafting, Stabilizer, Experimental model

Cite this paper: Abdurakhmanov A. A., Efficacy and Safety of New Myocardial Stabilizer for Off-Pump Coronary Artery Bypass Grafting, American Journal of Medicine and Medical Sciences, Vol. 11 No. 5, 2021, pp. 362-366. doi: 10.5923/j.ajmms.20211105.02.

1. Introduction

In 1910, Carrel [1] performed the first coronary artery bypass surgery using a preserved carotid artery (CA) on a beating heart in a dog. The world's first coronary artery bypass grafting in humans was performed by Kolesov in Leningrad in 1967 [2]. In April 1968, Rene Favaloro published the first series of coronary artery bypass grafting surgeries [3]. In the 50 years since this landmark publication, coronary artery bypass grafting (CABG) has been enthusiastically developed by cardiac surgeons around the world. This was followed by the widespread use of standard coronary artery bypass grafting (CABG), which became possible due to the development of cardiopulmonary bypass techniques with various approaches with or without cardioplegic protection. Currently, most coronary artery bypass grafting (CABG) procedures are performed using cardiopulmonary bypass (CPB). The use of CPB for CABG operations allows performing anastomosis of the coronary artery in a stable bloodless surgical field with myocardial protection, providing excellent long-term results [4]. However, cardiopulmonary bypass is associated with several side effects such as bleeding, neurological complications, tissue edema, myocardial damage, and potential problems with weaning the patient from the heart-lung machine [5,6,7]. Many of these complications can be attributed to mechanical and immunological changes in blood components [8,9]. In addition, cross-clamping of the aorta during the procedure may increase the risk of myocardial, aortic, and neurological complications [10]. More recently, the development of serious persistent cognitive defects in patients undergoing cardiopulmonary bypass was noted, regardless of its duration [11].
The development of the off-pump coronary artery bypass grafting technique became possible with the development of technical aspects proposed by Lima et al. In the 1990s, the technique using a series of pericardial retraction sutures allowed access to the arteries of the lateral surface of the heart [12]. Later, methods for improved visualization of the lateral wall were described using a traction suture in the oblique sinus of the pericardium [13]. Further improvement in the technique of beating heart surgery is associated with Grundeman and Borst [14-15], who improved the OPCAB operation by applying vacuum fixation technologies to expose and stabilize coronary vessels. They studied spatial motion and the biological effects of stabilized absorption in an experimental laboratory and proved the superior stabilization of this method.
By 1999, according to the Society of Thoracic Surgeons (STS), beating heart bypass grafts accounted for about 10% of the total volume of CABG operations performed in the United States, and by 2007 - already about 20% [16]. And now this method has both its supporters and skeptics. Until now, OPCAB does not exceed 20-25% in the USA, 19% in the UK, 5% in Canada, reaching 60-75% in the practice of individual surgeons [17-19]. The ability to stabilize or immobilize the surgical site can significantly improve surgical accuracy and reduce the time required to complete a specific procedure [20]. Methods and device for performing CABG on a beating heart are first described in the publications of Benetti et al. [23]. In some cases, devices that provide mechanical stabilization of the myocardium by compression encounter difficulties in providing mechanical pressure on the myocardial surface [21-22]. Similarly, devices that use a vacuum (vacuum stabilizers) have great difficulty in creating and maintaining effective "suction" to the moving surface of the heart [25]. Even when the beating heart has been effectively stabilized, the target coronary artery may be covered by layers of fat or other tissue, making it very difficult for the surgeon to visualize it. Moreover, the stabilizing devices can lead to the deformation of the tissue surrounding the coronary artery, or the coronary artery itself, so that the arteriotomy remains in an unfavorable position for anastomosis.
In the connection with above mentioned, it is important to have methods and devices for stabilizing the beating heart that are capable of maintaining atraumatic interaction with the surface of the beating heart over a wider range of conditions and orientations. Therefore, the development of simple and safe surgical methods that provide a stable and bloodless coronary anastomotic field is important for the successful CABG with a beating heart.
The aim of the study was to evaluate the newly developed myocardial stabilizer in an experimental model in dogs.

2. Material and Methods

This experimental study was performed in Experimental Department of Republican Research Center of Emergency Medicine (Tashkent. Uzbekistan), under the permission of the Republican Committee of Ethics during January 2021. Four mongrel dogs (12 to 20 kg) were included in this pilot study. Anesthetic management was provided with ketamine (20 mg / kg). The animals were artificially ventilated with 100% oxygen at a rate of 0.5 l / s. Neuromuscular blockers were not used in this study. Then the animals were prepared for hemodynamic monitoring. Heart rate was measured using a continuous electrocardiographic monitor (model 90903A; SpaceLabs Inc, Redmond, Washington). Arterial oxygen saturation was measured with a sensor (Pulse Oxymeter; Criticare Systems Inc, Redmond, WA) attached to the tongue (Figure 1).
Figure 1. Intraoperative photos describing the experimental technique and monitoring of experimental animals
Then a small anterior thoracotomy on the left side (8 cm) was performed in the fifth intercostal space, followed by complete mobilization of LIMA under direct visual control. The pericardium opposite to the LAD was fixed with silk sutures to the chest wall. At all stages of experimental interventions, hemodynamic parameters were continuously recorded. The newly developed stabilizer was set on the LAD, and artery was stabilized using rubber preservation sutures. The LIMA - LAD anastomosis was performed according to the standard technique using 8-0 Prolene sutures (Ethicon, Somerville, NJ). After making sure of adequate hemostasis and hemodynamic stability, the experimental intervention was completed in a standard manner, the pericardium was left open, the pleural cavity was drained with silicone drainage, followed by connection to a vacuum aspiration system. Than dog was transferred to the ICU (a special room in pet laboratory) and its vital functions were observed till extubation. Overall observation period consisted 7 days. All animals were provided with humane care in accordance with the UK National Medical Research Society's Guidelines for the Care and Use of Laboratory Animals and the Canadian Council on Animal Care (Association of Universities and Colleges of Canada) [26-27].

3. Results

All animals survived the procedure and maintained stable hemodynamic parameters both during and after manipulation (Table 1).
Table 1. Intraoperative parameters of experimental animals
     
The use of the stabilizer did not adversely affect heart rate, cardiac output, or arterial oxygen saturation (Figure 2).
Figure 2. Changes in key hemodynamic parameters before, during and after coronary artery bypass grafting using a myocardial stabilizer (BP - blood pressure; HR - heart rate)
As can be seen from the above graph, hemodynamic parameters and arterial blood saturation did not undergo any changes in dynamics, which allows us to conclude about the safety and effectiveness of the used myocardial stabilizer. Complications and deaths after the performed operations were not observed in experimental animals.

4. Discussion

Recent studies confirm that OPCAB should be considered technically more challenging than conventional CABG. To ensure optimal conditions for surgical intervention, three fundamental rules must be followed: the surgical field must be well open and accessible, stable and bloodless. During OPCAB, cardiac surgeons voluntarily violate these rules. However, to date, none of the available mechanical stabilization devices has been able to achieve a stable bloodless field comparable to the surgical field achieved with cardioplegic cardiac arrest and cardiopulmonary bypass. Moreover, a number of surgeons express doubts about the quality of coronary anastomoses in interventions on a beating heart. There is still no completely clear evidence. In 2001, Puskas et al. [28] reported an impressive 98% OPCAB patency rate at hospital discharge, while more recently Khan et al. [29] reported the results of a prospective randomized study with a graft patency rate at three months of 98% for patients operated on -pump, compared with 88% for patients operated off-pump (P = 0.002). The learning curve appears to play an important role in OPCAB, and many series have been published showing higher patency rates and lower incidence of unsatisfactory anastomoses as the surgeon grows in experience [30-31].
The movement of the heart occurs in three dimensions of space and can be described as a smoothly varying combination of sinusoidal waves, we found only a few publications in which the movement of the surface of the heart is quantified [32]. In a pig model, Borst et al. [33] calculated the two-dimensional area (x and y axes) covered by the control point on the epicardium during free heartbeat and after the installation of a mechanical vacuum stabilizer, showing a significant reduction in movement (from 73 ± 43 mm2 to 1.3 ± 0.5 mm2) at stabilization of the heart. Koransky et al., [34] analyzed the three-dimensional movement of the coronary artery LAD in pigs using sonomicrometry techniques. Movement and speed were analyzed alternately in the x, y and z planes using triangulation theory before and after placement of the vacuum stabilizer. Stabilization led to a significant decrease in travel (11.36 ± 1.74 versus 5.99 ± 1.30 mm; p <0.05), maximum Cartesian speed (141.80 ± 29.73 versus 86.55 ± 29.45 mm / s; p <0.05) and the average Cartesian LAD velocity (44.30 ± 7.02 versus 21.46 ± 4.54 mm / s; p <0.05). In their most recent study, Cattin et al., [35] showed significant reductions in maximum excursion, excursion speed, and trajectory deviation after LAD stabilization with an Octopus device in three pigs. These authors used an 8-bit high-speed black and white video camera (50 frames/s) in combination with a laser sensor (60 μm resolution) to capture the movement of the heart wall around the LAD in all three dimensions. In their experiments, the residual excursion of the coronary artery after stabilization was about 300–330 µm in the x and y plane and about 2–2.6 mm in the z plane.
The myocardial stabilizer developed by our team allows performing coronary artery bypass grafting on a beating heart. No undesirable effects on any of the measured hemodynamic parameters were observed when using this stabilizer. Despite the small diameter of the coronary arteries in dogs and a high heart rate, coronary artery bypass grafting was successful and was not accompanied by complications and mortality in the experimental part of the work.

5. Conclusions

It can be noted that the myocardial stabilizer developed by heart team of Republican Research Center of Emergency Medicine provides excellent stabilization of the target segments of the coronary artery and facilitates vascular anastomosis on the beating heart.

References

[1]  Carrel A. On the experimental surgery of the thoracic aorta and the heart. Ann Surg 1910; 52: 83–95. PubMed Abstract | Free Full Text.
[2]  Kolessov VI. Mammary artery–coronary artery anastomosis as method of treatment for angina pectoris. J Thorac Cardiovasc Surg 1967; 54: 535–544. PubMed Abstract.
[3]  Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann Thorac Surg. 1968 Apr; 5(4): 334-9. doi: 10.1016/s0003-4975(10)66351-5. PMID: 5647919.
[4]  Pfister AJ, Zaki MS, Garcia JM, et al. Coronary artery bypass without cardiopulmonary bypass. Ann Thorac Surg. 1992; 54: 1085-1092.
[5]  Downing SW, Edmunds Jr, LH Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg. 1992; 54: 1236-1243.
[6]  Ramkumar J, Gopinathan G, Kavin K, Shanmugasundaram R, Stephen GM, Pragasam AC, Thangavel P. Effects of cardiopulmonary bypass perfusion temperature on perioperative renal function in adult patients undergoing cardiac surgery. J Saudi Heart Assoc. 2020 Apr 17; 32(1): 40-45. doi: 10.37616/2212-5043.1007. PMID: 33154890; PMCID: PMC7640603.
[7]  Ryugo M, Monta O, Saitou S, Asada S, Tamagawa Y, Takehara T, Tsutsumi Y. [Risk Analysis of Acute Kidney Injury after Cardiac Surgery and Protective Effect by Less Invasive Surgery]. Kyobu Geka. 2020 Oct; 73(11): 895-900. Japanese. PMID: 33130709.
[8]  Hübner M, Tomasi R, Effinger D, Wu T, Klein G, Bender M, Kilger E, Juchem G, Schwedhelm E, Kreth S. Myeloid-Derived Suppressor Cells Mediate Immunosuppression After Cardiopulmonary Bypass. Crit Care Med. 2019 Aug; 47(8): e700-e709. doi: 10.1097/CCM.0000000000003820. PMID: 31149961.
[9]  Giacinto O, Satriano U, Nenna A, Spadaccio C, Lusini M, Mastroianni C, Nappi F, Chello M. Inflammatory Response and Endothelial Dysfunction Following Cardiopulmonary Bypass: Pathophysiology and Pharmacological Targets. Recent Pat Inflamm Allergy Drug Discov. 2019; 13(2): 158-173. doi: 10.2174/1872213X13666190724112644. PMID: 31339081.
[10]  Dubost A, De Gevigney G, Zambartas C, Milon H, Delahaye JP. L'infarctus du myocarde post-pontage. Facteurs associés et pronostic [Myocardial infarction after coronary bypass surgery. Associated factors and prognosis]. Arch Mal Coeur Vaiss. 1990 Jun; 83(7): 947-52. French. PMID: 2114854.
[11]  Bruggemans EF. Cognitive dysfunction after cardiac surgery: Pathophysiological mechanisms and preventive strategies. Neth Heart J. 2013 Feb; 21(2): 70-3. doi: 10.1007/s12471-012-0347-x. PMID: 23184600; PMCID: PMC3547425.
[12]  Lima RC, Escobar M, Wanderley Neto J, et al. Revascularização do miocárdio sem circulação extracorpórea: resultados imediatos. Rev Bras Cir Cardiovasc 1993; 8: 171–176.
[13]  Bergsland J, Karamanoukian HL, Soltoski PR, Salerno TA. “Single suture” for circumflex exposure in off-pump coronary artery bypass grafting. Ann Thorac Surg 1999; 68: 1428–1430. PubMed Abstract | Publisher Full Text.
[14]  Grundeman PF, Borst C, van Herwaarden JA, Verlaan CWJ, Jansen EWL. Vertical displacement of the beating heart by the octopus tissue stabilizer: influence on coronary flow. Ann Thorac Surg 1998;65:1348–1352.PubMed Abstract | Publisher Full Text.
[15]  Grunenfelder J, Comber M, Lachat M, Leskosek B, Turina M, Zund G. Validation of intracoronary shunt flow measurements for off-pump coronary artery bypass operations. Heart Surg Forum 2004; 7: 26–30. PubMed Abstract.
[16]  Gaudino M, Angelini GD, Antoniades C, et al; Arterial Grafting International Consortium (ATLANTIC) Alliance. Off-Pump Coronary Artery Bypass Grafting: 30 Years of Debate. J Am Heart Assoc. 2018 Aug 21; 7(16): e009934. doi: 10.1161/JAHA.118.009934. PMID: 30369328; PMCID: PMC6201399.
[17]  Ferguson TB, Jr, et al. A decade of change--risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg. 2002; 73(2): 480–489. doi: 10.1016/S0003-4975(01)03339-2. [PubMed] [CrossRef] [Google Scholar].
[18]  Hayatsu Y, Ruel M, Bader Eddeen A, Sun L. Single Versus Multiple Arterial Revascularization in Patients With Reduced Renal Function: Long-term Outcome Comparisons in 23,406 CABG Patients From Ontario, Canada. Ann Surg. 2020 Jun 24. doi: 10.1097/SLA.0000000000003908. Epub ahead of print. PMID: 32590546.
[19]  Weeks WB, Paraponaris A, Ventelou B. Geographic variation in rates of common surgical procedures in France in 2008-2010, and comparison to the US and Britain. Health Policy. 2014 Nov; 118(2): 215-21. doi: 10.1016/j.healthpol.2014.08.015. Epub 2014 Sep 8. PMID: 25260910.
[20]  Kowalewski M, et al. Off-pump coronary artery bypass grafting improves short-term outcomes in high-risk patients compared with on-pump coronary artery bypass grafting: Meta-analysis. J Thorac Cardiovasc Surg. 2016; 151(1): 60–77. doi: 10.1016/j.jtcvs.2015.08.042. [PubMed] [CrossRef] [Google Scholar].
[21]  Al-Ruzzeh S, et al. Is the use of cardiopulmonary bypass for multivessel coronary artery bypass surgery an independent predictor of operative mortality in patients with ischemic left ventricular dysfunction? Ann Thorac Surg. 2003; 76(2): 444–451. doi: 10.1016/S0003-4975(03)00348-5. [PubMed] [CrossRef] [Google Scholar].
[22]  Gal J, Grattan A, Kertai MD, Smith A, Shaw AD, Royston D, Riedel BJ. Coronary revascularization in transition from on-pump to off-pump: the effect of the off-pump coronary artery bypass on medium-term outcome. J Cardiovasc Surg (Torino). 2007 Feb;48(1):67-72. PMID: 17308524.
[23]  Benetti FJ Naselli G Wood M Geffner L. Direct myocardial revascularization without extracorporeal circulation. Chest. 1991; 100: 312-315.
[24]  Yamanaka J Takeuchi Y Gomi A Torii S Koyanagi T Yashima M. Coronary artery bypass grafting without cardiopulmonary bypass in patients with LV dysfunction (EF < or = 30%) — a report of 3 cases. J Jpn Assoc Thorac Surg. 1995; 43: 1069-1072.
[25]  Detter C, Deuse T, Christ F, Boehm DH, Reichenspurner H, Reichart B. Comparison of two stabilizer concepts for off-pump coronary artery bypass grafting. Ann Thorac Surg. 2002 Aug; 74(2): 497-501. doi: 10.1016/s0003-4975(02)03734-7. PMID: 12173835.
[26]  Poole TB. The UFAW Handbook on the care and management of laboratory animals. London: Longman Scientific & Technical; 1999.
[27]  Guide to the care and use of experimental animals Canadian Council on Animal Care; Association of Universities and Colleges of Canada. Ottawa, Ont.: The Council, c1980-198. NLM ID: 8705895 [Book].
[28]  Puskas JD, Thourani VH, Marshall JJ, Dempsey SJ, Steiner MA, Sammons BH, Brown WM 3rd, Gott JP, Weintraub WS, Guyton RA. Clinical outcomes, angiographic patency, and resource utilization in 200 consecutive off-pump coronary bypass patients. Ann Thorac Surg. 2001 May;71(5):1477-83; discussion 1483-4. doi: 10.1016/s0003-4975(01)02473-0. PMID: 11383786.
[29]  Khan NE, De Souza A, Mister R, Flather M, Clague J, Davies S, Collins P, Wang D, Sigwart U, Pepper J. A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med. 2004 Jan 1; 350(1): 21-8. doi: 10.1056/NEJMoa031282. PMID: 14702424.
[30]  Jegaden O, Mikaeloff P. Off-pump coronary artery bypass surgery. The beginning of the end? Eur J Cardiothorac Surg. 2001 Mar; 19(3): 237-8. doi: 10.1016/s1010-7940(01)00591-7. PMID: 11251258.
[31]  Carthey J, de Leval MR, Reason JT. The human factor in cardiac surgery: errors and near misses in a high technology medical domain. Ann Thorac Surg. 2001 Jul; 72(1): 300-5. doi: 10.1016/s0003-4975(00)02592-3. PMID: 11465216.
[32]  Lemma M, Mangini A, Redaelli A, Acocella F. Do cardiac stabilizers really stabilize? Experimental quantitative analysis of mechanical stabilization. Interact Cardiovasc Thorac Surg. 2005 Jun; 4(3): 222-6. doi: 10.1510/icvts.2004.098517. Epub 2005 Mar 29. PMID: 17670397.
[33]  Borst C, Jansen EW, Tulleken CA, Gründeman PF, Mansvelt Beck HJ, van Dongen JW, Hodde KC, Bredée JJ. Coronary artery bypass grafting without cardiopulmonary bypass and without interruption of native coronary flow using a novel anastomosis site restraining device ("Octopus"). J Am Coll Cardiol. 1996 May; 27(6): 1356-64. doi: 10.1016/0735-1097(96)00039-3. PMID: 8626944.
[34]  Koransky ML, Tavana ML, Yamaguchi A, Kown MH, Miniati DN, Nowlin W, Robbins RC. Quantification of mechanical stabilization for the performance of off-pump coronary artery surgery. Heart Surg Forum. 2003; 6(4): 224-31. PMID: 12928205.
[35]  Cattin P, Dave H, Grünenfelder J, Szekely G, Turina M, Zünd G. Trajectory of coronary motion and its significance in robotic motion cancellation. Eur J Cardiothorac Surg. 2004 May; 25(5): 786-90. doi: 10.1016/j.ejcts.2004.01.019. PMID: 15082283.